“The Spending Review rightly acknowledges the importance of tobacco cessation for the sustainability of the NHS and prevention of disease with at least £80million being invested in cessation and enforcement annually. However, this is less than current spending,” ASH CEO Hazel Cheeseman commented on this week’s Spending Review.


